PROVIDER PROFILE · NPI 1720030109

Ibrez BandukwalaMD

PRACTICELAUREATE MEDICAL GROUP AT NORTHSIDE LLCSee all providers at this practice →

Internal MedicineAtlanta, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

5,134

Unique beneficiaries

—

Total services

7,789

Distinct HCPCS

Medicare payment

$239K

Peer benchmark

Total Medicare services vs. 2,751 Internal Medicine providers in GA — top quintile (cohort median 670).

PRESCRIBING · PART D · 2024

Total Rx claims

7,428

Beneficiaries

—

Total drug cost

$519K

Distinct drugs

101

Brand share

15.5%

Top prescribed drugs

Atorvastatin Calcium773 claims

Rosuvastatin Calcium683 claims

Ezetimibe555 claims

Amlodipine Besylate413 claims

Losartan Potassium312 claims

QUALITY · MIPS · 2024

Final MIPS score

80.9

Quality

76.2

Cost

70.2

Improvement activities

40.0

Promoting interop.

88.0

Payment adjustment

0.25%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$202

Payment records

By payment type

Food and Beverage$202

REFERRAL NETWORK

Where Ibrez Bandukwala's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NORTHSIDE HOSPITAL, INC.	54	141
CRAWFORD LONG HOSPITAL	26	45
Scott Leibowitz Sleep Medicine · Atlanta, GA	12	34
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	12	19

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history